Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Genentech key operating metrics including Phase I Trials Products, environmental, and social and governance score (ESG).

Phase I Trials Products

28

Jul, 2025

Phase II Trials Products

19

Jul, 2025

US FDA Breakthrough Therapy Designations

40

Jul, 2025

Operating Metrics

MetricsJul, 2025
Phase I Trials Products28
Phase II Trials Products19
US FDA Breakthrough Therapy Designations40
Medicines and Products49
Active Clinical Trials270
Phase III Trials Products41
Collaborations220

Environmental, Social and Governance (ESG)

Overall

50-59 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal
Learn more

Source:CSRHub

Footer menu